Santen Pharmaceutical Co., Ltd. (SNPHY)

Santen Pharmaceutical Revenue

Santen Pharmaceutical had revenue of 68.74B JPY in the quarter ending June 30, 2025, a decrease of -8.07%. This brings the company's revenue in the last twelve months to 293.97B, down -3.41% year-over-year. In the fiscal year ending March 31, 2025, Santen Pharmaceutical had annual revenue of 300.00B, down -0.65%.

• Revenue (ttm): 293.97B JPY
• Revenue Growth: -3.41%
• P/S Ratio: 1.65
• Revenue / Employee: 76.38M JPY
• Employees: 3,849
• Market Cap: 3.37B USD

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	300.00B	-1.96B	-0.65%
Mar 31, 2024	301.97B	22.93B	8.22%
Mar 31, 2023	279.04B	12.78B	4.80%
Mar 31, 2022	266.26B	16.65B	6.67%
Mar 31, 2021	249.61B	8.05B	3.33%